Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 326

1.

Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study.

Caniglia EC, Cain LE, Sabin CA, Robins JM, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage GR 3rd, Bonnet F, Dabis F, Moore RD, Reiss P, van Sighem A, Mathews WC, Del Amo J, Moreno S, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Napravnik S, Jose S, Phillips A, Justice AC, Tate JP, Gill J, Pacheco A, Veloso VG, Bucher HC, Egger M, Furrer H, Porter K, Touloumi G, Crane H, Miro JM, Sterne JA, Costagliola D, Saag M, Hernán MA; HIV-CAUSAL Collaboration.; Centers for AIDS Research Network of Integrated Clinical Systems..

Lancet HIV. 2017 Apr 11. pii: S2352-3018(17)30043-7. doi: 10.1016/S2352-3018(17)30043-7. [Epub ahead of print]

PMID:
28411091
2.

Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression.

Ntamatungiro AJ, Muri L, Glass TR, Erb S, Battegay M, Furrer H, Hatz C, Tanner M, Felger I, Klimkait T, Letang E; KIULARCO Study Group..

J Antimicrob Chemother. 2017 Apr 6. doi: 10.1093/jac/dkx095. [Epub ahead of print]

PMID:
28387865
3.

Mining for pairs: shared clinic visit dates identify steady HIV-positive partnerships.

Marzel A, Shilaih M, Turk T, Campbell NK, Yang WL, Böni J, Yerly S, Klimkait T, Aubert V, Furrer H, Calmy A, Battegay M, Cavassini M, Bernasconi E, Schmid P, Metzner KJ, Günthard HF, Kouyos RD; Swiss HIV Cohort Study (SHCS)..

HIV Med. 2017 Apr 4. doi: 10.1111/hiv.12507. [Epub ahead of print]

PMID:
28378387
4.

Incidence and risk factors for hypertension among HIV patients in rural Tanzania - A prospective cohort study.

Rodríguez-Arbolí E, Mwamelo K, Kalinjuma AV, Furrer H, Hatz C, Tanner M, Battegay M, Letang E; KIULARCO Study Group..

PLoS One. 2017 Mar 8;12(3):e0172089. doi: 10.1371/journal.pone.0172089. eCollection 2017.

5.

Intestinal colonisation with extended-spectrum cephalosporin- and colistin-resistant Enterobacteriaceae in HIV-positive individuals in Switzerland: molecular features and risk factors.

João P, Bernasconi OJ, Hauser C, Tinguely R, Atkinson A, Perreten V, Donà V, Rauch A, Furrer H, Endimiani A.

Int J Antimicrob Agents. 2017 Apr;49(4):519-521. doi: 10.1016/j.ijantimicag.2017.02.004. Epub 2017 Feb 27. No abstract available.

PMID:
28254374
6.

Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study.

Gebreselassie HM, Kraus D, Fux CA, Haubitz S, Scherrer A, Hatz C, Veit O, Stoeckle M, Fehr J, de Lucia S, Cavassini M, Bernasconi E, Schmid P, Furrer H, Staehelin C; Swiss HIV Cohort Study (SHCS)..

HIV Med. 2017 Mar 1. doi: 10.1111/hiv.12491. [Epub ahead of print]

PMID:
28247589
7.

Update of the Swiss guidelines on post-treatment Lyme disease syndrome.

Nemeth J, Bernasconi E, Heininger U, Abbas M, Nadal D, Strahm C, Erb S, Zimmerli S, Furrer H, Delaloye J, Kuntzer T, Altpeter E, Sturzenegger M, Weber R, For The Swiss Society For Infectious Diseases And The Swiss Society For Neurology.

Swiss Med Wkly. 2016 Dec 5;146:w14353. doi: 10.4414/smw.2016.14353. eCollection 2016. Review.

8.

Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.

Chêne G, Phillips A, Costagliola D, Sterne JA, Furrer H, Del Amo J, Mocroft A, d'Arminio Monforte A, Dabis F, Miro JM, Barger D, Termote M, Schwimmer C, Salbøl Brandt R, Friis-Moller N, Raben D, Haerry D, Egger M, Weller I, De Wit S.

Int J Epidemiol. 2016 Nov 17. pii: dyw211. [Epub ahead of print] No abstract available.

PMID:
27864413
9.

Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.

Gueler A, Moser A, Calmy A, Günthard HF, Bernasconi E, Furrer H, Fux CA, Battegay M, Cavassini M, Vernazza P, Zwahlen M, Egger M; Swiss HIV Cohort Study, Swiss National Cohort..

AIDS. 2017 Jan 28;31(3):427-436. doi: 10.1097/QAD.0000000000001335.

10.

Clinical Course, Radiological Manifestations, and Outcome of Pneumocystis jirovecii Pneumonia in HIV Patients and Renal Transplant Recipients.

Ebner L, Walti LN, Rauch A, Furrer H, Cusini A, Meyer AM, Weiler S, Huynh-Do U, Heverhagen J, Arampatzis S, Christe A.

PLoS One. 2016 Nov 8;11(11):e0164320. doi: 10.1371/journal.pone.0164320. eCollection 2016.

11.

CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART.

Sauter R, Huang R, Ledergerber B, Battegay M, Bernasconi E, Cavassini M, Furrer H, Hoffmann M, Rougemont M, Günthard HF, Held L; and the Swiss HIV cohort study..

Medicine (Baltimore). 2016 Oct;95(42):e5094.

12.

Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions.

Salazar-Vizcaya L, Kouyos RD, Zahnd C, Wandeler G, Battegay M, Darling KE, Bernasconi E, Calmy A, Vernazza P, Furrer H, Egger M, Keiser O, Rauch A; Swiss HIV Cohort Study..

Hepatology. 2016 Dec;64(6):1856-1869. doi: 10.1002/hep.28769. Epub 2016 Oct 19.

13.

Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.

Béguelin C, Moradpour D, Sahli R, Suter-Riniker F, Lüthi A, Cavassini M, Günthard HF, Battegay M, Bernasconi E, Schmid P, Calmy A, Braun DL, Furrer H, Rauch A, Wandeler G; Swiss HIV Cohort Study..

J Hepatol. 2017 Feb;66(2):297-303. doi: 10.1016/j.jhep.2016.10.007. Epub 2016 Oct 14.

PMID:
27746337
14.

Prevalence and Outcomes of Hepatitis B Coinfection and Associated Liver Disease Among Antiretroviral Therapy-Naive Individuals in a Rural Tanzanian Human Immunodeficiency Virus Cohort.

Ramírez-Mena A, Glass TR, Winter A, Kimera N, Ntamatungiro A, Hatz C, Tanner M, Battegay M, Furrer H, Wandeler G, Letang E.

Open Forum Infect Dis. 2016 Jul 29;3(3):ofw162. eCollection 2016 Sep.

15.

Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern.

Muri L, Gamell A, Ntamatungiro AJ, Glass TR, Luwanda LB, Battegay M, Furrer H, Hatz C, Tanner M, Felger I, Klimkait T, Letang E; KIULARCO Study Group..

AIDS. 2017 Jan 2;31(1):61-70.

16.

Opportunistic Diseases During HIV Infection-Things Aren't What They Used to Be, or Are They?

Furrer H.

J Infect Dis. 2016 Sep 15;214(6):830-1. doi: 10.1093/infdis/jiw086. Epub 2016 Apr 18. No abstract available.

PMID:
27559121
17.

New holostean fishes (Actinopterygii: Neopterygii) from the Middle Triassic of the Monte San Giorgio (Canton Ticino, Switzerland).

López-Arbarello A, Bürgin T, Furrer H, Stockar R.

PeerJ. 2016 Jul 19;4:e2234. doi: 10.7717/peerj.2234. eCollection 2016.

18.

Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do better.

Darling KE, Hachfeld A, Cavassini M, Kirk O, Furrer H, Wandeler G.

Swiss Med Wkly. 2016 Aug 21;146:w14348. doi: 10.4414/smw.2016.14348. eCollection 2016. Review.

19.

Polyclonal Intestinal Colonization with Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae upon Traveling to India.

Pires J, Kuenzli E, Kasraian S, Tinguely R, Furrer H, Hilty M, Hatz C, Endimiani A.

Front Microbiol. 2016 Jul 12;7:1069. doi: 10.3389/fmicb.2016.01069. eCollection 2016.

20.

Dynamic models for estimating the effect of HAART on CD4 in observational studies: Application to the Aquitaine Cohort and the Swiss HIV Cohort Study.

Prague M, Commenges D, Gran JM, Ledergerber B, Young J, Furrer H, Thiébaut R.

Biometrics. 2017 Mar;73(1):294-304. doi: 10.1111/biom.12564. Epub 2016 Jul 26.

Supplemental Content

Loading ...
Support Center